Arterys
Financials
Estimates*
USD | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Revenues | 16.6m | 30.0m | 30.0m | 7.9m | 8.6m | 8.6m |
% growth | - | 81 % | - | (74 %) | 9 % | - |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$1.7m | Seed | ||
N/A | Seed | ||
N/A | Early VC | ||
$7.0m | Series A | ||
$12.0m | Series A | ||
N/A | Grant | ||
$30.0m | Series B | ||
N/A | Convertible | ||
* | $28.0m | Series C | |
Total Funding | $78.7m |
Recent News about Arterys
EditArterys operates in the healthcare sector, specializing in medical imaging enhanced by artificial intelligence (AI). The company serves healthcare providers, including hospitals and clinics, by integrating AI-driven clinical applications into existing Picture Archiving and Communication Systems (PACS) or Electronic Health Records (EHR) workflows. This integration allows for seamless adoption of advanced diagnostic tools without disrupting current practices. Arterys' platform is cloud-based, ensuring accessibility from any validated device, which enhances performance and deployment ease while maintaining data security. The business model revolves around a subscription-based service, where clients pay for access to the AI tools and platform. Revenue is generated through these subscriptions and potentially through partnerships with other healthcare technology providers. The platform's key features include improved diagnostic accuracy, enhanced physician experience, and better financial performance for healthcare providers. Arterys aims to transform healthcare by leveraging deep learning and AI to extract actionable insights from medical images, thereby improving clinical decision-making, efficiency, and productivity.
Keywords: medical imaging, AI, healthcare, diagnostics, PACS, EHR, cloud-based, deep learning, clinical applications, physician workflow.